I think it will be better regarded on Nasdaq But we are a bit dumber here when it comes to biotechs Personally the group buying a share of the future direction of medicine and then using their own clinics is breathtakingly clever We know some indications already have insurance rebate numbers ...just need to get FDA on board and all those DD back issues which cripple you with pain are on the conveyer belt continuously into your own clinics using your own doctors supplied by your own biologic Five years time the island looks achievable
I think it will be better regarded on Nasdaq But we are a bit...
-
- There are more pages in this discussion • 7,794 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |